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ABSTRACT  
Background: Tuberculosis (TB), the second leading cause of death among infectious diseases 
continues to be a major public health threat worldwide, more so in the developing world. 
Several strategies have been tried in the past to address its burden, including Directly 
Observed Therapy Short-course (DOTS), DOTS plus, and the Stop TB Strategy. Amid these 
efforts, TB is now listed amongst the top re-emerging diseases in the world. This study 
identified trends in TB case detection, major type of TB, patient demographics, AFB positive 
rates, and treatment outcomes within the period reviewed. 
Methods: In this descriptive records review of years 2011-2015, existing data was extracted 
from tuberculosis central registers from all sites in Delta State, Nigeria. The data was analysed 
using winPEPI and EPIDATA software solutions and presented in tables and charts. 
Results: Tuberculosis case detection declined between 2011 and 2015. Patients aged 25–34 
years were the largest proportion. Males outnumbered females in total but the proportion of 
females was higher among 5 to 34 year olds. Treatment success rate improved from 68.3% in 
2011 to 88.0% in 2014. Sputum AFB positive rate was <60% for 2011 – 2014 but rose above 
70% in 2015. Prevalence of extra-pulmonary TB was 2% for all the years reviewed except 2013 
which had a small variation. The proportion of patients lost to follow-up declined from 2011 
through 2015. 
Conclusion: The Delta State Tuberculosis Control Programme improved in case-holding. 
These gains need to be sustained to keep up with the stipulations of the National Tuberculosis 
Control Programme. 
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INTRODUCTION 
Mycobacterium tuberculosis infection is a major 
infectious cause of deaths globally, mostly in 
developing countries.1 It is still the second 
leading cause of death among the infectious 
diseases and continues to be a major public 
health threat worldwide. It is a debilitating 
disease with a greater prevalence and severity 
in a background of reduced immunity. In 
more recent years, it has become even more 
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complex due to a rise in its drug-resistant 
strains, amidst a range of other issues 
including human immunodeficiency virus 
(HIV) co-infection and TB (tuberculosis) co-
morbidities - diabetes, congestive heart failure, 
asbestosis, sarcoidosis, etc.2 Several strategies 
for tuberculosis control were formulated 
through the mid-twentieth to the twenty-first 
centuries, namely DOTS, DOTS plus and the 
Stop TB strategy intended to reduce the 
burden of this disease.3, 4 Amid all efforts to 
control TB, the tide is not abating; instead it is 
reappearing in almost epidemic proportions 
and now listed amongst the top re-emerging 
diseases, mainly because of increasing multi-
drug resistance and co-infection with human 
immunodeficiency virus (HIV). Till date, no 
other disease in history matches the sheer 
magnitude of the misery inflicted by TB on the 
human race in terms of morbidity and 
mortality.5 
In Nigeria, tuberculosis is one of the top public 
health problems, ranking fourth among the 30 
high-burden TB countries in the world.5 There 
were 90,447 TB cases notified in 2010 with 
41,416 (58%) new smear positive cases, and a 
case detection rate of 40% in Nigeria.6 
Although targets were set to reverse the 
incidence, half the prevalence and mortality, 
diagnose 70 percent  of new smear-positive 
cases and cure 85 percent of tuberculosis cases 
by 2015, for many countries, these targets were 
not achieved despite the current existence of 
interventions.7, 8 New TB cases were estimated 
to be 10.6 million globally in 2016, with 1.4 
million deaths and an additional 0.4 million 
deaths among persons co-infected with 
human immunodeficiency virus; 95% of these 
occurred in developing countries.9 With the 
setting up of the national tuberculosis control 
programme in 1989 several strategies, 
including DOTS, have been adopted to combat 
the persistently high burden of TB in Nigeria. 
10  However, the gains of such interventions 
only became profound in the last decade when 
STOP TB strategy was introduced so much 
that within a period of five years (2006-2010) 
the death rate from TB was halved.6 
In Delta State, though the incidence was as 
high as 2500 new cases recorded in 2010, with 
intensified efforts towards elimination the 
figures for new TB cases have reduced 
significantly in subsequent years. 6 The policy 
of the national programme in Nigeria is for all 
patients to be treated free of charge using 
DOTS strategy for six months in pulmonary 
TB cases, and twelve months for TB meningitis 
and spine. In many developing countries 
including Nigeria, Sputum Smear Microscopy 
(SSM) is the most widely used test for the 
diagnosis of pulmonary tuberculosis in 
accordance with the International Standards on 
Tuberculosis Care.11, 12 The implementation of 
DOTS, which has been long established in 
Nigeria, is practised through sites distributed 
in the various states of the country. Since the 
national programme has set targets and 
indicators for the tuberculosis control in 
Nigeria, it is imperative that we assess the 
performance of the Delta State TB programme. 
This would enable us identify its achievements 
and opportunity areas and enlighten 
stakeholders on the way forward. This study 
therefore aimed to provide a summary 
description of patients who received DOTS for 
tuberculosis in Delta State, Nigeria. The  
prevalence of tuberculosis, age/sex 
distribution, new smear positive cases, the 
major type of TB seen, and treatment outcomes 
including cure rates, failure, loss to follow up 
(LTFU) and death rates among tuberculosis 
patients managed at DOTS centres over a five–
year period were reported. 
METHODOLOGY 
This descriptive study involving the use of 
pre-existing data (from January, 2011 through 
December, 2015) from all ninety-eight TB-
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DOTS sites in the three senatorial zones of 
Delta State was conducted in a period from 
March - June, 2017. 
Brief description of TB-DOTS in Delta state: 
There are 98 DOTS centres spread across all 25 
LGAs in the state and a TB referral centre in 
Ethiope-East LGA. Each centre is manned by 
health workers who report to the Local 
Government TB Programme Control Officer 
who is accountable to the State TB Control 
Programme Coordinator.  
Data collection: Data was extracted from a 
standardized and updated State Tuberculosis 
Central Registry using a proforma. The State 
Tuberculosis Central Registry from which data 
extracted was up-to-date at the time of this 
study and the challenge with missing data was 
circumvented. 
Ethical consideration: Ethical clearance was 
obtained from the Ethical Review Board of 
Delta State Ministry of Health, Asaba before 
conducting this study. Patient confidentiality 
was maintained throughout the study as no 
information that could personally identify 
them was used. 
Data analysis: Data was analysed to identify 
trends using Microsoft Excel, winPEPI and 
Epidata software solutions. The results were 
represented using frequency tables and charts. 
RESULTS  
The total number of TB patients seen at DOTS 
clinics in Delta State in the five years reviewed 
was 13,635. There was a steady yearly decline 
in the number of TB cases from 2011 to 2015: 
the count in 2011 was 3076 while that in 2015 
was 2349. The rate of decline slowed down 
between 2014 and 2015. Each year, age group 
25–34 years made up the highest proportion of 
patients presenting for treatment at DOTS 
clinics (average: males - 24.7%; female - 29.8%); 
while ages 0-4 years was the smallest 
proportion (average: males - 1.0%; female - 
1.2%). Although the proportion of females was 
higher than the males, for age groups 5-14 
(males: 2.1%, Females: 3.7%), 15-24 (males: 
13.4%, females: 18.5%) and 25-34 (males: 
24.7%, females: 29.8%) years, the relative 
number of males was consistently higher than 
that of females for all the years reviewed. 
(Table 1) Each year, age-group 25–34 years 
made up the modal age group of new sputum 
smear positive TB cases presenting at DOTS 
clinics. The next highest frequencies were seen 
in age groups 35-44 years and 15-24 years. 
There was less than an average of 1 (0.1%) case 
of sputum smear positive TB among 0–4 year 
olds in the 5 years reviewed. Sputum smear 
positive TB was more common among males 
for all age groups except among 5–34 years 
olds where the proportions were higher 
among females. (Table 2) 
There was a consistent decline in the total 
number of TB cases seen each year: from 3076 
in 2011 to 2349 in 2015; but the proportion of 
AFB positive cases fluctuated during the years 
reviewed. AFB+/N ratio were as follows: 
2011: 51.8%, 2012: 56.4%, 2013: 54.0%, 2014: 
56.1%, and 2015: 70.6%. (Figure 1) Although 
total number of TB patients on DOTS care was 
on the decline, the proportion of new patients 
registering into the program each year was on 
the increase from 2011 through 2015. The 
newly registered cases were 85.5% in 2011 and 
gradually rose to 97.8% in 2015 except for 2012 
when newly registered cases constituted 93.9% 
which was higher than the newly registered 
cases in 2013. (Figure 2) The relative 
proportion of pulmonary tuberculosis (PTB) 
and extra-pulmonary tuberculosis (EPTB) 
cases that presented at DOTS centres in Delta 
State was nearly constant for the 5 years 
reviewed. Proportion of Extra-pulmonary TB 
was 2% of patients for all the years with a small 
variation in 2013. (Figure 3) Documented cure 
rate for patients ranged from 35.6% to 45.4% 
with the highest being in 2014. Treatment 
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completion rate without documented cure 
fluctuated between 32.7% and 43.2% between 
2011 and 2015. Treatment success rate 
therefore varied between 68.3% and 88.6%. 
Loss to follow-up rate was disproportionately 
high in 2011 at 25% compared to the other 
years which were below 10%. Death rate was 
similar for the 5 years reviewed ranging from 
4.3% to 5.4 %. (Table 3) 
DISCUSSION 
The control of tuberculosis continues to be 
topical as the burden and complexity of the 
disease is still a source of much concern both 
globally and locally. This review of TB records 
in Delta State, Nigeria showed a steady decline 
in the total number of TB cases seen at DOTS 
centres over the 5 years reviewed. This  decline 
is likely due to consistency in control efforts in 
the last decade, and this finding is consistent 
with the reports of the CDC for the  United 
States in 2014.13 It is important that strategies 
that have worked be reinforced for better 
performance, and if new strategies are to be 
introduced, they must have been proven to 
out-perform these. Sex distribution with 
respect to prevalence of tuberculosis in this 
study was similar to that from a study 
conducted within same Delta State14 and in 
other studies in western and eastern Nigeria 
where the prevalence of tuberculosis amongst 
males was generally greater than that of 
females.15–17 This finding is also in keeping 
with some studies from outside Nigeria where 
male predominance was observed.18,19  
The World Health Organization asserts that 
prevalence of tuberculosis is higher in females 
in countries like Nigeria where the prevalence 
of HIV is above 1%.20 It would appear that the 
findings of this study contradict that mindset, 
and that would be surprising especially as the 
prevalence of HIV in Nigeria is 3.2% and 4.1% 
in Delta State, the location of this review.21 
However, a closer observation reveals that 
although the total number of male patients 
was generally more than that of females, for 
ages 5-34 years, the collective proportion of 
females with TB and positive for AFB was 
consistently greater than that of males for all 
the 5 years reviewed. This is more consistent 
with the WHO assertion of a female 
preponderance in high burden HIV countries. 
20 This could likely be the effect of HIV and due 
to the fact that transgenerational sex and 
marriage are somewhat common in this 
environment.22,23 Public health authorities and 
other stakeholders must add the findings of 
this study to their cache of amoury to 
engender social change in matters like this that 
so clearly impact on public health negatively. 
The decline in TB cases as well as the 
increasing trend of AFB positive cases over the 
five years was unlike findings from a similar 
study in Enugu State which showed a rising 
trend of TB cases despite a decline in the 
proportion of AFB positive cases.15AFB 
positive cases in this study were 
disproportionately higher in 2015 and did not 
align with the generally decreasing TB trend. 
This may have been due to the recent 
introduction of Xpert MTB/Rif in the 
diagnosis of TB. The findings of this study 
with respect to sex and age patterns of sputum 
smear positive PTB correlate with reports from 
a recent study in southern Nigeria,24 and are 
consistent with the documented global 
epidemiology of the disease.25 It is not at all 
surprising that the rate of positive AFB tests 
were very low among children generally and 
almost virtually nil amongst under-fives. 
Diagnosing TB in children continues to pose a 
great challenge to TB management globally as 
it is difficult to collect sputum samples from 
children, and even when sputum is produced, 
it is usually “paucibacillary” and thus smear 
negative. 26  This has rendered the current 
modalities for diagnosis of tuberculosis 
insufficient for use in children. New 
modalities like the Quantiferon Gold test 
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which use biomarkers expressed in other body 
fluids are being perfected for use in TB 
diagnosis.26 They will definitely reduce 
diagnostic dilemmas which are currently a 
common trend among children and immune-
suppressed persons. 
A predominance of pulmonary tuberculosis, 
as seen in this study (98%), was also reported 
by studies of patients treated at DOTS centres 
in South-western Nigeria, Eastern Nigeria, 
and Europe where 94.8%, 86.5% and 80.3% of 
the patients had pulmonary tuberculosis, 
respectively.17, 27, 28 Hospital wide infectious 
disease profiles have shown PTB to still 
present a high burden in many settings. In fact, 
prevalence rates from reviews in North-West 
Ethiopia, Kano Nigeria, and Saudi Arabia 
were 14.7%, 43.8%, 10.3%, respectively.29–31 
However, the high prevalence could be due to 
over diagnosis of PTB largely from reliance on 
chest X-ray reports, case definitions and 
clinical findings instead of the standard AFB 
or Xpert MTB/Rif tests. Extra-pulmonary 
tuberculosis was more prevalent in other 
studies in Ibadan, Oyo State, and Nnewi, 
Anambra State, Nigeria and another study in 
Europe with a prevalence of 15.6%, 13.5% and 
19.3%, respectively,27, 28, 32 than in this review 
where only about 2% had EPTB each year for 
the five years reviewed. The reason for this 
could be over diagnosis or higher co-infection 
with HIV in those studies. A higher prevalence 
of 51.2% and 56.2% of EPTB, have been 
recorded in studies in north-west Ethiopia.30, 33 
The reasons for this is not immediately 
obvious although it is possible that EPTB is 
under-diagnosed in the setting of this study 
because of the difficulties involved with 
sample collection for diagnosing EPTB and 
maybe because AFB is not sufficient for this 
purpose.  
This study revealed that over a period of five 
years, the proportion of patients who had 
successfully completed their TB treatment 
gradually increased from 68.3% in 2011 to 
88.0% in 2014 and some decline in 2015. This 
finding is in contrast with findings of a study 
in Southern Ethiopia where successful 
completion of TB treatment declined from 68% 
to 50% over a period of ten years.34 
Documented cure rate for patients in this 
review fluctuated between 35.6% and 45.4% 
which was rather inconsistent and low 
compared to the WHO recommended TB cure 
rate of 85%.10However, this corroborated 
findings from a study conducted in Eku, Delta 
State, Nigeria where the cure rate was 45.7%.14 
This finding is probably a result of the 
inconsistencies in the system of provision of 
DOTS services in Delta State. These 
inconsistencies could have included poor 
record keeping, 35 lack of or poor follow-up 
services and reminder systems, and possibly, 
inconsistencies with timing of clinics. Several 
studies from India, Pakistan, Iraq and Mexico 
reported varying cure rates; 42.9%, 55%, 
63.5%, 69.6% and 82.7% respectively.19, 36–39 
Also, the efficacy of current TB drugs is in 
question and there is ongoing research to 
produce more effective drugs for TB 
treatment.26 There may also be a need to 
expand services for testing and management 
of drug-resistant TB in Delta State; as this may 
improve cure rates. 
The loss to follow-up rate of patients attending 
DOTS clinics observed in this study, steadily 
declined from 25% to 4.3% for the first four 
years. However, there was a slight increase to 
6.1% in the fifth year. These findings were 
mostly lower than values obtained from Eku, 
Delta State where loss to follow-up (LTFU) 
rate was observed to be 12.9% over a five-year 
period.14 This implies that LTFU is generally 
better in other parts of Delta State than at Eku 
which is only one of the ninety-eight DOTS 
centres in Delta State. LTFU in this study was 
worse compared to that observed in North-
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West Ethiopia where it was reportedly low at 
2.5%.34 The differences observed between 
these studies may be attributed to the general 
challenges observed in the delivery of health 
care services, including DOTS in Nigeria. 
The treatment failure rate in this study was 
below 3% for the years reviewed and similar 
to 2.7% reported from a previous study in 
eastern Nigeria.27 This suggests that TB drug 
resistance may be low in Delta State even 
though it is among the high burden States for 
TB in Nigeria.40 Death rate among TB patients 
observed in this study ranged from 4.3% to 
5.4%. These rates were similar to those from 
studies conducted in Abuja, Nigeria and 
Felige, Ethiopia where death was reported to 
be 4.9% and 5.8%, respectively. 30, 41 Slightly 
lower mortality rates of 3%, 2.7%, and 3.6% 
recorded from previous studies in Mexico and 
India indicate a likely generally better 
outcome of treatment for patients in those 
countries.38, 39, 42 However, these findings were 
in contrast to reports from a study in Saudi 
Arabia where TB mortality rate was 18%.31 
Although death rate in this study was 
markedly lower than that in the Saudi Arabian 
study; the probable reason for this could be 
because more than half of the patients in the 
Saudi study had associated co-morbidities. It 
also needs to be borne in mind that the 
treatment outcomes of patients lost to follow-









Tuberculosis is common in all age groups in 
Delta State but most prevalent in the third and 
fourth decades of life but treatment outcomes 
do not meet the WHO recommendations. 
Although prevalence has been on the decline 
since 2011, documented cure rates leave much 
to be desired. Extra-pulmonary Tuberculosis 
rate has been stable at about 2% but this may 
actually be due to under-diagnosed. In the 
active years of life, females bear a higher 
burden of TB. This finding may need further 
exploration and social interventions to curb it 
if the suspected underlying factors are 
identified. 
Recommendation 
Public health authorities and other 
stakeholders could act on the findings of this 
study to improve TB (pulmonary and extra-
pulmonary) diagnosis by adopting innovative 
modalities to reduce diagnostic delays and 
dilemmas commonly experienced in TB 
management and care in the state.  
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Table 1: Distribution of TB patients at DOTS centres in Delta State from 2011 - 2015 







                                                                                 Sex of patients   





      
 





      2011        2012       2013         2014        2015 Average no. (%) 
M F M F M F M F M F M F 
0-4 24 (1.3) 16 (1.3) 15 (0.9) 14 (1.1) 18 (1.1) 18 (1.5) 15 (1.1) 13 (1.3) 8 (0.6) 5 (0.5) 16 (1.0) 13 (1.2) 
5-14 38 (2.1) 39 (3.2) 43 (2.5) 64 (5.1) 32 (2.0) 48 (4.0) 22 (1.6) 28 (2.8) 33 (2.4) 31 (3.3) 34 (2.1) 42 (3.7) 
15-24 220 (12.0) 228 (18.5) 243 (14.3) 214 (17.0) 222 (13.8) 222 (18.1) 203 (14.4) 188 (18.9) 183 (13.1) 198 (20.9) 214 (13.4) 210 (18.5) 
25-34 517 (28.0) 402 (32.6) 425 (25.0) 379 (30.0) 395 (24.5) 362 (29.5) 351 (24.9) 297 (30.0) 279 (21.2) 248 (26.1) 393 (24.7) 338 (29.8) 
35-44 419 (22.7) 246 (20.0) 396 (23.2) 282 (22.3) 396 (24.5) 252 (20.5) 337 (24.0) 221 (22.3) 337 (24.1) 221 (23.3) 377 (23.6) 244 (21.5) 
45-54 290 (15.7) 143 (11.6) 265 (15.6) 143 (11.3) 264 (16.4) 154 (12.5) 227 (16.1) 118 (11.9) 270 (19.3) 131 (13.8) 263 (16.5) 138 (12.2) 
55-64 172 (9.3) 88 (7.1) 165 (9.7) 91 (7.2) 140 (8.7) 89 (7.2) 133 (9.4) 60 (6.0) 161 (11.5) 59 (6.2) 154 (9.7) 78 (6.9) 
≥65 164 (8.9) 70 (5.7) 152 (9.0) 75 (6.0) 146 (9.1) 83 (6.7) 122 (8.7) 68 (6.8) 129 (9.2) 56 (5.9) 143 (9.0) 70 (6.2) 
Sub-total 1844 (60.0) 1232 (40.0) 1704 (57.5) 1262 (42.5) 1613 (56.8) 1228 (48.2) 1410 (58.7) 993 (41.3) 1400 (59.6) 949 (40.4) 1594 (58.5) 1133 (41.5) 
Total      3076 (100.0)       2966 (100.0)       2841 (100.0)       2403 (100.0)          2349 (100.0) 2727 (100.0) 
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                                                                        Sex of patients  
 






      2011       2012        2013       2014       2015 Average No. (%) 
M F M F M F M F M F M F 
0-4 1 (0.1) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 2 (0.2) 0 (0.0) 1 (0.1) 0 (0.0) 
5-14 9 (1.0) 21 (3.4) 13 (1.3) 20 (3.0) 8 (0.9) 13 (2.0) 11 (1.4) 10 (1.8) 14 (1.4) 16 (2.4) 11 (1.2) 16 (2.6) 
15-24 147(15.1) 163(26.3) 175 (17.3) 148(22.5) 132(14.9) 158(24.4) 136(17.0) 121(22.2) 143(14.3) 160(24.2) 147(15.7) 150(23.9) 
25-34 307(31.6) 219(35.3) 282 (27.8) 215(32.6) 260(29.3) 204(31.5) 209(26.1) 181(33.2) 225(22.6) 189(28.5) 256(27.4) 202(32.2) 
35-44 231(23.7) 120(19.4) 258 (25.4) 154(23.4) 229(25.8) 137(21.2) 205(25.6) 121(22.2) 253(25.4) 154(23.3) 235(25.2) 137(21.9) 
45-54 155(16.0) 54 (8.7) 158 (15.6) 63 (9.6) 134(15.1) 72 (11.1) 121(15.1) 62 (11.4) 192(19.3) 76 (11.5) 152(16.3) 65 (10.4) 
55-64 68 (7.0) 23 (3.7) 72 (7.1) 32 (4.9) 72 (8.1) 37 (5.7) 68 (8.5) 28 (5.1) 103(10.3) 35 (5.3) 76 (8.1) 31 (4.9) 
≥65 55 (5.6) 20 (3.2) 56 (5.5) 27 (4.1) 53 (6.0) 26 (4.0) 51 (6.3) 23 (4.2) 66 (6.6) 32 (4.8) 56 (6.0) 26 (4.1) 
Sub-total 973(61.1) 620(38.9) 1014(60.6) 659(39.4) 888(57.9) 647(42.1) 801(59.5) 546(40.5) 997(60.1) 662(39.9) 934(59.8) 627(40.2) 
 Total      1593 (100.0)       1673 (100.0)       1535 (100.0)       1347 (100.0)        1659 (100.0) 1561 (100.0) 
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AFB+/N Ratio (%) 51.8 56.4 54.0 56.1 70.6 
N refers to the total number of tuberculosis patients seen each year consecutively for the 5 years reviewed 
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Figure 3: Proportions of Pulmonary and Extra-pulmonary Tuberculosis at DOTS Clinics 
 
 
Table 3: Trends in treatment outcomes for all new cases of tuberculosis in Delta State 
Outcomes                                      Years in review 
                                      Frequency (%) 
 
2011 (n=1593) 2012 (n=1673) 2013 (n=1535) 2013  (n=1347) 2015 (n=1659) 
Cured (a) 567 (35.6) 706 (42.2) 682 (44.4) 611 (45.4) 720 (43.40 
      
Treatment 
completed (b) 
521 (32.7) 709 (42.4) 642 (41.9) 574 ( 42.6) 717 (43.2) 
      
Treat failure 11 (0.7) 17 (1.0) 17 (1.1) 11(0.8) 15 (0.9) 
      
Loss to follow-up 398 (25.0) 107 (6.4) 71 (4.6) 58 (4.3) 101 (6.1) 
      
Transfer 27 (1.7) 54(3.2) 40 (2.6) 23 (1.7) 25 (1.5) 
      
Died 69 (4.3) 80 (4.8) 83 (5.4) 70 (5.2) 81 (4.9) 
      
Treatment 
success (a + b) 
1088 (68.3) 1415 (84.6) 1324 (86.3) 1195 (88.0) 1437 (86.6) 
 
2% 2% 1.80% 2% 2.00%
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